Clinical Investigation

Kidney International (1989) 36, 114–119; doi:10.1038/ki.1989.169

Clinical Profiles and erythrocyte Na+ transport abnormalities of four major types of primary hypertension in Spain

Alejandro De la Sierra1, Antonio Coca1, María T Aguilera1, Miguel Ingelmo1 and Alvaro Urbano-Márquez1

1Hypertension Research Group, Department of General Internal Medicine, Hospital Clinico, Villarroel 170, Barcelona, Spain

Correspondence: Dr Antonio Coca, Servicio de Medicina Interna General, Hospital Clinico, Villarroel 170, 08036 Barcelona, Spain.

Received 19 September 1988; Revised 27 February 1989; Accepted 2 March 1989.

Top

Abstract

Clinical profiles and erythrocyte Na+ transport abnormalities of four major types of primary hypertension in Spain. The interaction of three different Na+ transport systems (Na+-K+ pump, Na+-K+ cotransport and Na+-Li+ countertransport), with internal Na+ and the passive Na+ leaks, were measured in erythrocytes from 72 Spanish, essential hypertensive patients and 30 normotensive controls. According to the observed abnormalities in Na+ transport pathways, 93.1% of the patients were classified into the following subsets: 12 (16.7%) exhibited a decreased apparent affinity of Na+-K+ pump for internal Na+ (Pump "-" hypertensives); 20 (27.7%) showed a decreased apparent affinity of Na+-K+ cotransport for internal Na+ (Co "-" hypertensives); 27 (37.5%) showed an accelerated Na+-Li+ countertransport (Counter " + " hypertensives); and 5 (6.9%) exhibited an increased rate constant of passive Na+ leaks (Leak " + " hypertensives), finally, 5 patients (6.9%) did not show any abnormality in their Na+ transport systems and 3 exhibited more than one. Moreover, distinctive clinical features were recognized in Co "-" and Counter " + " subsets. Blood pressure values were lower in the former and, conversely, Counter " + " hypertensives showed a higher prevalence of moderate or severe hypertension (65.57% vs. 32.6%; P = 0.0059) and higher values of stimulated plasma renin activity (1.63plusminus 0.52 vs. 0.81 plusminus 0.15; P = 0.0443). Our results confirm the heterogeneity of Na+ transport abnormalities in essential hypertension and suggest that these subsets of hypertensives could represent clinical entities.

Top

References

  1. Laragh JH: Personal views on the mechanism of hypertension, in Hypertension: Physiopathology and Treatment (2nd ed), edited by, Genest J, Kuchel O, Hamet P, Cantin M, New York, McGraw-Hill, 1983, pp. 615–631
  2. Wessels FG, Junge-Hulsing G, Losse M: Untersuchungen zur Natrium permeabilität der Erythrozyten bei Hypertonikern und Normotonikern mit familiärer Hochdruckbelastung. Z Kreislauff 56:374–380, 1967
  3. Garay RP, Nazaret C: Na+ leak in erythrocytes from essential hypertensive patients. Clin Sci 69:613–624, 1985
  4. Diez J, Hannaert P, Garay R: Kinetic study of the Na+,K+-pump in erythrocytes from essential hypertensive patients. Am J Physiol 252:H1–H6, 1987
  5. De la Sierra A, Coca A, Aguilera MT, Urbano Marquez A: Abnormal Na+-K+ ATPase kinetics in a subset of essential hypertensive patients. Eur J Clin Invest 18:337–342, 1988
  6. Garay RP, Nazaret C, Hannaert P, Price M: Abnormal Na+, K+ cotransport function in a group of patients with essential hypertension. Eur J Clin Invest 13:311–320, 1983
  7. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302:772–776, 1980 | PubMed | ISI | ChemPort |
  8. Garay RP, Nazaret C, Dagher G, Bertrand E, Meyer P: A genetic approach to the geography of hypertension: Examination of Na+-K+ cotransport in Ivory Coast Africans. Clin Exp Hypertens 3:861–870, 1981 | PubMed | ChemPort |
  9. Tuck ML, Corry DB, Maxwell M, Stern N: Kinetic analysis of erythrocyte Na+-K+ pump and cotransport in essential hypertension. Hypertension 10:204–211, 1987
  10. Adragna NC, Canessa ML, Solomon H, Slater E, Tosteson DC: Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension. Hyperten sion 4:795–804, 1982
  11. Mongeau JG: Erythrocyte cation fluxes in essential hypertension of children and adolescents. Int J Pediatr Nephrol 6:41–46, 1985
  12. Canessa M, Bize I, Solomon H: Na countertransport and cotransport in human red cells: Function, dysfunction and genes in essential hypertension. Clin Exp Hypertens 3:783–795, 1981
  13. Canessa M, Brugnara C, Escobales N: The Li+-Na+ exchange and Na+-K+-Cl- cotransport systems in essential hypertension. Hypertension 10 (Suppl I):I4–I10, 1987
  14. Garay RP, Nazaret C, Diez J: Stimulation of K fluxes by diuretic drugs in human red cells. Biochem Pharmacol 33:2013–2020, 1984
  15. Garay RP: Kinetic aspects of red blood cell sodium transport systems in essential hypertension. Hypertension 10(Suppl I):I11–114, 1987
  16. Dixon WJ, Brown MB, Engelman L: BMDP Statistical Software. Berkeley, University of California Press, 1985
  17. SPSS Inc: SPSSx User's Guide. New York, McGraw-Hill, 1986
  18. Dahl LK: Salt intake and hypertension, in Hypertension: Physio pathology and Treatment, edited by, Genest J, Koiw E, Kuchel O, New York, McGraw-Hill, 1977, pp. 548–559
  19. Garay R, Rosati C, Meyer P: Na+ transport in primary hyper tension. Ann NY Acad Sci 488:187–195, 1986
  20. Canessa M, Bize I, Adragna N, Tosteson DC: Cotransport of lithium and potassium in human red cells. J Gen Physiol 80:149–168, 1982
  21. Brugnara C, Canessa M, Cusi D, Tosteson DC: Furosemide-sensitive Na and K fluxes in human red cells. J Gen Physiol 87:91–112, 1986
  22. Garay RP, Meyer P: A new test showing abnormal net Na+ and K+ fluxes in erythrocytes of essential hypertensive patients. Lancet 1:349–353, 1979
  23. Hannaert PA, Garay RP: A kinetic analysis of Na-Li counter-transport in human red blood cells. J Gen Physiol 87:353–368, 1986
  24. Canessa M: The polymorphism of red cell Na and K transport in essential hypertension: Findings, controversies and perspectives, in Erythrocyte Membrane 3: Recent Clinical and Experimental Advances. Prog Clin Biol Res, Vol 159, 1984, 293–315
  25. Trevisan M, Ostrow D, Cooper R: Abnormal red blood cell ion transport and hypertension. The people's gas company study. Hypertension 5:363–367, 1983 | PubMed |
  26. Garay RP, Nazaret C, Hannaert P: A classification of essential hypertensive patients according to the erythrocyte Na+ transport abnormalities: An application for monitoring the antihypertensive response to cicletanide. Klin Wochenschr63 (Suppl III):30–32, 1985
  27. Wessels F, Zumkley H: New aspects concerning the 22Na influx into red cells in essential hypertension. Klin Wochenschr 63 (Suppl III):38–41, 1985
  28. Wessels F, Zumkley H: Sodium metabolism of RBC in hypertensive patients, in Intracellular Electrolytes and Arterial Hypertension, edited by, Zumkley H, Losse H., Stuttgart, Georg Thieme Verlag, 1980, pp. 59–68
  29. Simon G, Conklin DJ: In vivo erythrocyte sodium concentration in human hypertension is reduced, not increased. J Hypertens 4:71–75, 1986
  30. De Wardener HE, MacGregor GA: The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine 62:310–326, 1983 | PubMed | ChemPort |
  31. Parker JC, Berkowitz LR: Physiologically instructive genetic variants involving the human red cell membrane. Physiol Rev 63:261–313, 1983
  32. Weder AB: Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 314:198–201, 1986 | PubMed | ISI | ChemPort |
  33. Mulvany MJ: Changes in sodium pump activity and vascular contraction. J Hypertens 3:429–436, 1985
  34. Nakazato Y, Ohga A, Onoda Y: The effect of ouabain on noradrenaline output from peripheral adrenergic neurons of isolated guinea pig vas deferens. J Physiol 278:45–54, 1978
  35. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation and hypertension: A reassessment and a hypothesis. Am J Physiol 232:C165–C173, 1977 | PubMed | ISI | ChemPort |

Extra navigation

.
ADVERTISEMENT